NL-OMON49706撤回3 期
Continuous low dose subcutaneous lidocaine for treatment of pneumonia in COVID*19 patients. A randomised controlled (RCT) open*label phase III study. - Not applicable
Stichting Dutch Covid19 Lidocaine ARDS0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 撤回
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •1. Age *18 years.
- •2. Acute disease with radiographic*
- •confirmed pneumonia with a positive test for COVID*19.
- •3.Patients admitted to the hospital ward with spontaneous breathing are eligible
- •for inclusion in the study.
排除标准
- •Patients known with allergy or hypersensitivity to lidocaine, xylocaine or ligno
- •2. Treatment with Ivermectin. Reportedly, Ivermectin inhibits the in*
- •vitro replication of SARS*1 CoV*2.
- •3. Treatment with methylprednisolone as sepsis therapy.
研究者
相似试验
撤回
3 期
Continuous low dose subcutaneous lidocaine for treatment of the symptoms of COVID*19. A randomised controlled open*label phase III study.NL-OMON49145Julius Clinical100
已完成
不适用
idocaine with ketamine in posterior spine fusioAnaesthesiaPACTR202103785412583Mostafa Mansour Hussein60
Unknown
4 期
The effectiveness of intravenous lidocaine to reduce coughing during laryngeal mask airway insertioGeneral anesthesia with laryngeal mask airway insertionIntravenous lidocaine, Laryngeal mask airwayTCTR20221207002Khon Kaen University74
已完成
4 期
idocaine for reducing pain from intravenous Nefopam infusiopain from nefopam injectionpain,nefopam,vascular painTCTR20201125006none42
已完成
2 期
The effect of low dose intravenous lidocaine premedication on fentanyl induced cough in general anesthesiaTCTR20180221002Phramongkutklao Hospital128